Comprehensive solutions for Clinical Development of generic drugs

Synene has developed more than 100 assays for conducting BA/BE studies across small molecules and biologics.

Author

Latest Blogs

Why CDMO Outsourcing is Moving Earlier in Biologics Development

Infographic showing the shift from traditional pharma outsourcing based on cost and capacity to a new-age CRDMO model focused on scientific depth, speed, supply-chain resilience, integration, and development flexibility.

The New-Age CRDMO: Rethinking Drug Development Partnerships

Flow Chemistry Approaches for Poorly Soluble Pharmaceutical Intermediates

Advanced Strategies for Handling Unstable Intermediates with Flow Chemistry

Electrochemical cell design: Turning electron transfer into a practical synthetic tool

Semi-targeted integration in cell line development supports stable clone selection and more predictable biologics development.

From Faster CLD to Smarter CMC Decisions: How Semi-Targeted Integration Changes the Biologics Game